Article
Doxorubicin Improves Cancer Cell Targeting by Filamentous Phage Gene Delivery Vectors
23 Oct 2020
Abstract excerpt
Merging targeted systemic gene delivery and systemic chemotherapy against cancer, chemovirotherapy, has the potential to improve chemotherapy and gene therapy treatments and overcome cancer resistance. We introduced a bacteriophage (phage) vector, named human adeno-associated virus (AAV)/phage or AAVP, for the systemic targeting of therapeutic genes to cancer. The vector was designed as a hybrid between a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
